Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?

September 23, 2023 updated by: Turgut Donmez, Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Study is designed to investigate whether the history of ERCP is associated with subtotal cholecystectomy rates in patients underwent laparoscopic cholecystectomy operations with the diagnosis of acute cholecystitis.

Study Overview

Detailed Description

The results of patients who underwent surgery for acute cholecystitis in a single center between January 2016 and December 2019 were included and evaluated retrospectively.

Primary outcome was subtotal cholecystectomy rate. Secondary outcomes were conversion to open, complications and serious complications. Within examining demographic findings, operative records (rates for subtotal cholecystectomy and conversion to open, operative duration) and follow-up results (postoperative complications, serious complications, length of hospital stay and mortality) for all cases were investigated. Complications that Clavien-Dindo Score ≥ 3 accepted as serious complication. Intraoperative detection of gallbladder perforation was also noted and included in comparison. Any biliary tract complication that needed any percutaneous or endoscopic intervention to handle was named as "biliary leak" in the study.

Study Type

Observational

Enrollment (Actual)

470

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Bakırkoy Dr.Sadi Konuk Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

- Patients operated with the diagnosis of acute cholecystitis a single center between January 2016 and December 2019.

Description

Inclusion Criteria:

  • Patients operated with the diagnosis of acute cholecystitis with an age greater or equal to 18 years old in a single center between January 2016 and December 2019

Exclusion Criteria:

  • Initial and direct preferance of open method
  • Being diagnosed with malignity after histopathological evaluation
  • Being operated just before one week after ERCP or after more than six weeks after ERCP

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Standard (non-ERCP) Group
Patients who underwent surgery for acute cholecystitis without a previous ERCP history.
Patients separated to two groups according to having a ERCP history before the operation
ERCP group
Patients who underwent surgery for acute cholecystitis with a previous ERCP history.
Patients separated to two groups according to having a ERCP history before the operation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subtotal Cholecystectomy Rate
Time Frame: Intraoperative
Rate of patients needed subtotal cholecystectomy after initial intent of starting laparoscopic to the cholecystectomy
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conversion to open
Time Frame: Intraoperative
Rate of patients needed conversion to open after initial intent of starting laparoscopic to the cholecystectomy
Intraoperative

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: Postoperative first 90 days
Any complications experienced by patients who underwent emergency operation with the diagnosis of acute cholecystitis
Postoperative first 90 days
Duration of operation
Time Frame: Intraoperative
Duration of emergency with the diagnosis of acute cholecystitis
Intraoperative
Length of hospital stay
Time Frame: Postoperative first 90 days
Number of days patient stayed with and after the emergency operation with the diagnosis of acute cholecystitis
Postoperative first 90 days
Mortality
Time Frame: Postoperative first 90 days
Number of patients that died after the emergency operation with the diagnosis of acute cholecystitis
Postoperative first 90 days
Serious complications
Time Frame: Postoperative first 90 days
Any complications that has a Clavien-Dindo Score ≥ 3 experienced by patients who underwent emergency operation with the diagnosis of acute cholecystitis. (Clavien Dindo Score System that classifying post-operative complications in 5 main levels. Higher the score, the more significant complications. While level 1 is the lightest, level 5 means death)
Postoperative first 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Mehmet Karabulut, University of Health Sciences, Bakirkoy Dr.Sadi Konuk Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2022

Primary Completion (Actual)

January 10, 2023

Study Completion (Actual)

January 25, 2023

Study Registration Dates

First Submitted

February 5, 2023

First Submitted That Met QC Criteria

February 5, 2023

First Posted (Actual)

February 14, 2023

Study Record Updates

Last Update Posted (Actual)

September 26, 2023

Last Update Submitted That Met QC Criteria

September 23, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cholecystectomy, Laparoscopic

Clinical Trials on ERCP

Subscribe